XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 383.6 $ 279.3 $ 1,049.6 $ 795.0
Cost of products sold 298.4 199.1 795.5 566.2
Gross profit 85.2 80.2 254.1 228.8
Selling expense 13.2 9.0 34.2 27.3
Research and development expense 5.7 3.6 14.9 10.4
General expense 41.4 24.6 126.7 77.9
Total nonmanufacturing expenses 60.3 37.2 175.8 115.6
Restructuring and impairment expense 1.9 6.0 5.9 7.7
Operating profit 23.0 37.0 72.4 105.5
Interest expense 15.3 7.8 31.3 22.8
Other income (expense), net 3.7 (1.0) 0.8 (0.7)
Income before income taxes and income from equity affiliates 11.4 28.2 41.9 82.0
Provision for income taxes 1.5 4.8 12.4 15.5
Income from equity affiliates, net of income taxes 2.3 1.1 6.1 2.0
Net income $ 12.2 $ 24.5 $ 35.6 $ 68.5
Net income per share - basic:        
Net income per share - basic (in dollars per share) $ 0.38 $ 0.78 $ 1.13 $ 2.19
Net income per share – diluted:        
Net income per share - diluted (in dollars per share) $ 0.38 $ 0.78 $ 1.12 $ 2.18
Weighted average shares outstanding:        
Basic (in shares) 31,046,100 30,909,700 31,022,100 30,805,300
Diluted (in shares) 31,401,000 31,142,500 31,381,600 31,020,100